Nutrients and supplements that support cardiovascular function, healthy blood pressure, and heart wellness.
17 itemsMTHFR C677T is common and usually benign. Learn what it means for folate, homocysteine, and real-world health, plus practical, food-first steps grounded in evidence.
Resveratrol’s promise meets pharmacokinetics: how low bioavailability shapes human results, what sirtuin research really suggests, and which delivery strategies are emerging.
The ITP’s rapamycin results show strong lifespan extension in mice via mTORC1 inhibition. Here’s how that connects to caloric restriction, ongoing human and dog trials, risks, and natural mTOR modulators—and why excitement is tempered by caution.
A focused review of how CoQ10 underpins cellular energy, how aging and statins intersect with CoQ10 biology, and where clinical research signals potential benefits—plus forms and PQQ as a complement.
Electrolytes matter—but not always the way sports drink ads suggest. This evidence-based guide covers sodium, potassium, and magnesium balance, hyponatremia risks, sweat variability, oral rehydration science, and how traditional options like coconut water and broth can fit into smart hydration for performance.
EPA vs. DHA ratios, oxidation concerns, triglyceride vs. ethyl ester forms — the definitive guide to choosing the right omega-3.
Glycinate, threonate, citrate, oxide — not all magnesium is created equal. A comprehensive breakdown of forms, absorption, and what each one does best.
Coenzyme Q10, a naturally occurring antioxidant involved in cellular energy production, commonly used for heart health and mitochondrial support.
A rich source of EPA and DHA omega-3 fatty acids, commonly used to support cardiovascular health and reduce inflammation.
An essential mineral involved in over 300 enzymatic reactions, commonly supplemented for muscle relaxation, sleep, and stress support.
Magnesium glycinate is a chelated form of magnesium bound to the amino acid glycine. This combination offers superior bioavailability compared to common forms like magnesium oxide (which has only 4% absorption) while being notably gentle on the digestive system. Magnesium is a cofactor in more than 300 enzymatic reactions in the human body, required for ATP production, protein synthesis, blood sugar regulation, blood pressure management, nerve transmission, and muscle contraction. It is essential for bone structure and plays a direct role in the active transport of calcium and potassium across cell membranes. Despite its critical importance, roughly 50% of Americans fail to meet the recommended daily intake. Subclinical deficiency — levels low enough to impair function but not low enough to trigger obvious symptoms — may affect up to 60% of the population. The glycine component provides additional benefits: glycine is an inhibitory neurotransmitter that supports sleep quality and has calming effects on the central nervous system, making magnesium glycinate particularly well-suited for evening use.
Omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — are polyunsaturated fats that the human body cannot synthesize de novo. They must be obtained from dietary sources, primarily fatty fish (salmon, mackerel, sardines, anchovies), shellfish, and marine algae. EPA and DHA serve as structural components of cell membranes throughout the body, with particularly high concentrations in the brain (DHA comprises roughly 40% of polyunsaturated fatty acids in the brain) and retina. Beyond structural roles, they are precursors to specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — that actively resolve inflammation rather than simply suppressing it. The evidence base for omega-3 supplementation is extensive. Large-scale trials and meta-analyses support benefits for cardiovascular health (triglyceride reduction, modest blood pressure lowering), inflammatory conditions, mood disorders, and cognitive maintenance. The American Heart Association recommends at least two servings of fatty fish per week, and higher-dose EPA supplementation has been shown to reduce cardiovascular events in the REDUCE-IT trial.
Hypertension is a leading modifiable risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, and premature mortality. Western guidelines (ACC/AHA 2017) lowered the diagnostic threshold to 130/80 mm Hg, reflecting data that cardiovascular risk rises continuously with higher pressures. Diagnosis relies on accurate measurement, confirmation with home or ambulatory monitoring when appropriate, and risk stratification. First-line therapy pairs lifestyle measures—particularly the DASH eating pattern with sodium restriction and regular physical activity—with medications when indicated. Large trials (ALLHAT, SPRINT) shape current practice: thiazide-type diuretics remain foundational and, in high-risk patients, targeting lower systolic pressures can further reduce events, albeit with more adverse effects, underscoring the need for individualized care and close follow-up. Resistant hypertension warrants a systematic approach to adherence, secondary causes, and addition of mineralocorticoid receptor antagonists. Eastern and traditional systems contribute complementary perspectives. In Traditional Chinese Medicine (TCM), hypertension is framed through pattern differentiation (e.g., liver yang rising, kidney yin deficiency), guiding use of formula-based herbal therapy (such as Tian Ma Gou Teng Yin, which contains Uncaria rhynchophylla/gou teng) alongside lifestyle, stress regulation, and practices like tai chi. Ayurvedic medicine emphasizes constitutional balance and employs botanicals such as Terminalia arjuna (arjuna) and historically Rauwolfia serpentina (source of reserpine, an early antihypertensive), together with diet, yoga, and meditation. Mind–body interventions (yoga, meditation, tai chi) have moderate evidence for small but meaningful blood pressure reductions and also improve adherence and stress resilience. Specific nutraceuticals—including garlic preparations and possibly coenzyme Q10—show small average reductions in systolic and di‑s
Alzheimer’s disease (AD) and cardiovascular disease (CVD) are tightly linked along a brain–heart axis. They share many modifiable risk factors—hypertension, diabetes, dyslipidemia, obesity, smoking...
Diabetes and hypertension commonly occur together and amplify each other’s risks for heart attack, stroke, kidney disease, retinopathy, and heart failure. Roughly two-thirds of adults with type 2 d...
Heart disease and diabetes are tightly linked cardiometabolic conditions that frequently co-occur and amplify each other’s risks. Cardiovascular disease (CVD)—including coronary artery disease, str...
Sleep apnea—most commonly obstructive sleep apnea (OSA)—and hypertension have a bidirectional, clinically important relationship. OSA is highly prevalent among people with elevated blood pressure a...
